Skip to page content

StoriesMore

VulnCheck Anthony Bettini
News
babson finale
News
inno madness 2024_TBBJ
News
cambridge skyline best crop
News
mi22 2023 2
News
Guy Fieri
News
2024 Build With Us @ Suffolk cohort
News
Measles research
News
Sam Altman
News
Boston Speaks Up Cam Brown
Profiles
14 Motif FoodWorks Phyical Lab Credit Webb Chappell
Profiles
Aleia Bucci, Jeremiah Pate
Profiles
Guy Hudson
Profiles
Boston Speaks Up Aisha Chottani
Profiles
Waeve Founders
Profiles
Boston Speaks Up Mike Salguero
Profiles
Pamela Shaddock, co-founder and Dianne Austin, CEO
Profiles
Jake Tamarkin, CEO of Everyday Life Insurance
Profiles
Crumpled one dollar bills on blue background
Inno Insights
Sports gambling
Inno Insights
Venture capital
Inno Insights
Compensation
Inno Insights
Financial growth
Inno Insights
Proptech startups
Inno Insights
Corporate investments
Inno Insights
Sam Bankman-Fried, FTX
Inno Insights
Hand grasping at fluttering money
Inno Insights

More

Apr
10
TBJ

See All Events

Want to stay ahead of who & what is next? Sent daily, the Beat is your definitive look at Boston’s innovation economy, offering news, analysis & more on the people, companies & ideas driving your city forward. Follow the Beat.

Sign Up
Apr
10
TBJ

See All Events

SpotlightMore

See More
See More
See More
See More
See More
See More

Thought Leadership from our Partners

April 19, 2024

Roxbury Community College has named four finalists to become its next president, with each coming from outside the school.

April 19, 2024

For the seventh consecutive year, Maine-based Bangor Savings took the top spot in New England on a national retail banking satisfaction survey.

April 19, 2024

It’s been seven months since the MBTA ended express train trips from Worcester to Boston without explanation. Now, there's a chance for the express to be back on track.

April 19, 2024

The university is "maximizing our real estate assets, including the partial lease of select spaces on campus," according to a spokesperson.

April 19, 2024

The Watertown startup has an ambitious goal of developing vaccines that provide lifelong protection from cancer and infectious diseases.